Stay updated with breaking news from Chrissy Trank. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval is based on results from the Phase 3 KEYNOTE-A39 trial, which demonstrated a superior overall survival benefit with KEYTRUDA plus Padcev versus platinum-based chemotherapy (gemcitabine plus cisplatin or carboplatin) in these patientsApproval expands the use of KEYTRUDA plus Padcev for locally advanced or me...
RAHWAY, N.J.--(BUSINESS WIRE)--Oct 5, 2023--
First positive Phase 3 results for WELIREG from LITESPARK-005 showed statistically significant improvements in PFS versus everolimus in these patientsRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from LITESPARK-005,...
First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patientsRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...